Canada Markets closed

ESSA Pharma Inc. (EPI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
9.07+0.07 (+0.78%)
At close: 3:55PM EDT

ESSA Pharma Inc.

999 West Broadway
Suite 720
Vancouver V5Z 1K5

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. David Ross ParkinsonPres, CEO & Director626.81kN/A1950
Mr. David S. WoodChief Financial Officer311.52kN/A1957
Mr. Peter A. VirsikExec. VP & COO544.66kN/A1971
Dr. Marianne D. SadarScientific Advisor136.05kN/A1961
Dr. Alessandra CesanoChief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

Corporate Governance

ESSA Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.